Novavax appears to have completed its monthly and weekly trend decline. Currently, it has broken the falling trend and is in an upward trend and Butterfly has formed. There is a possibility that it will rise to $200 in the long term and to $70 in the medium term. May you have plenty of profits. It is not an investment recommendation.
Komen:
Target-1 and Target-2 achieved their goals. Congratulations to the reviewers.